Retinopathy of prematurity in extremely premature infants

Ronald G W Teed1, Richard A Saunders

  • 1Storm Eye Institute, Medical University of South Carolina, Department of Ophthalmology, Charleston, South Carolina 29425-6760, USA. teed@musc.edu

Insights

Extremely premature infants (<25 weeks estimated gestational age) show higher rates of retinopathy of prematurity (ROP), including severe Type 1 ROP. However, the overall incidence may be lower than previously thought, with birth weight not significantly impacting Type 1 ROP risk in this group.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Perinatal Medicine

Background:

  • Retinopathy of prematurity (ROP) remains a significant concern in extremely premature infants.
  • Increasing survival rates of infants born before 27 weeks estimated gestational age (EGA) necessitate updated ROP incidence and severity data.
  • Previous ROP studies may not reflect current outcomes in the most vulnerable premature populations.

Purpose of the Study:

  • To compare the incidence and characteristics of ROP in infants born <25 weeks EGA versus those born 25 to 27 weeks EGA.
  • To evaluate the development of Type 1 ROP in these distinct extremely premature infant groups.
  • To assess the influence of birth weight and postmenstrual age on ROP development.

Main Methods:

  • Retrospective chart review of 231 infants born before 27 weeks EGA.
  • Infants categorized into two groups: <25 weeks EGA and 25 to 27 weeks EGA.
  • Analysis of ROP incidence, Type 1 ROP development, and associated factors like birth weight and postmenstrual age.

Main Results:

  • ROP developed in 87% of infants <25 weeks EGA compared to 62% in the 25 to 27 weeks EGA group.
  • Type 1 ROP occurred in 23% of infants <25 weeks EGA versus 9% in the 25 to 27 weeks EGA group.
  • Lower birth weight predicted Type 1 ROP risk in the 25-27 weeks EGA group, but not in the <25 weeks EGA group; no difference in diagnosis age.

Conclusions:

  • Extremely premature infants (<25 weeks EGA) have a higher likelihood of developing ROP and severe Type 1 ROP.
  • The incidence of ROP in this cohort may be lower than previously reported.
  • Birth weight and postmenstrual age do not appear to be significant predictors for Type 1 ROP in the <25 weeks EGA group.
Abstract